Wondering about...I've been a shareholder since the run last February. Bought on dips and sold some recently. Still holding a lot of shares and might reload if this sinks more. But a thought, or concern I have. It seems these guys take advantage of current hype to release news that seems sorta fluffy, but attempts to raise the share price. First it was the InMed term sheet, then hiring a cannabinoid doctor, and most recently hiring a block chain expert. At first I thought these news releases were good, but now after the recent block chain news, I'm kinda wondering what these guys true motive is. Is it just to put out fluff news to capitalize on the current hype of the day, only to drive the share price up? What does a biotech company need anything to do with block chain, at least at this point of their game?
If if it wasn't for their completed phase 2b trials and orphan drug designator, I'd be completely out of these guys today at $0.32. I'm betting large that these guys get something developed and takes us to over dollar land, but I'm getting a bit worried. Also their office picture from google maps certainly isn't impressive. I guess they don't need much, but seems pretty small.
Anyway, just sharing concerns to see what others think.
also, kimkwest is back, so prepare for this board to get overly sexual